Consumer Marketing briefs

Share this article:
Pharma websites are consistent only in that they're nearly all confusing, said a pair of academics who reviewed product sites for the 100 best-selling drugs. Dartmouth prof Lewis Glinert and Jon Schommer of the University of Minnesota's Department of Pharmaceutical Care and Health Systems, said their review found that most product sites lack a linear narrative or conclusion, contain “an unpredictable mix of information and promotion, content, verbal style, visuals and layout,” and often present risk and safety information in small fonts, cumbersome blocks and other unreadable formats.

Boehringer Ingelheim launched a Facebook game aimed at encouraging healthier habits among people with diabetes. The game, called HealthSeeker, encourages users to attain “lifestyle goals” like improving their diet and lowering blood sugar levels.

Pfizer is reviewing the advertising business for Advil, Advertising Age reported. The brand, formerly part of the Wyeth Consumer Health portfolio, spent $80 million in measured media on marketing last year. The incumbent shop on the brand is WPP's ghg, and several East Coast agencies are vying against ghg for the business, Ad Age reported.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?